Floatz logo

Anti-Tumor Necrosis Factor Receptor Superfamily Member 8 Chimeric Antigen Receptor T Cells

Lymphoma, Extranodal NK-T-Cell

National Cancer Institute (NCI)Cell therapyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Lymphoma, Extranodal NK-T-Cell cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
International Extranodal Lymphoma Study Group (IELSG)
Phase 3BB
PREDNISONE TABLETS
Sun Yat-sen University
Phase 3BB
Eloxatin
Sun Yat-sen University
Phase 3BB
ETOPOSIDE
Sichuan University
Phase 3BB
Inno-206
Sun Yat-sen University
Phase 3BB

View all 24 →

Same molecule, other indications

Anti-Tumor Necrosis Factor Receptor Superfamily Member 8 Chimeric Antigen Receptor T Cells is also rated in:

anaplastic large cell lymphomaDormant
CC
Indicative ·
47 / 100
View asset →
peripheral T-cell lymphoma, not otherwise specifiedDormant
CC
Indicative ·
47 / 100
View asset →
enteropathy-associated T-cell lymphomaDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →